Interacting Drugs |
Boceprevir vs Ticagrelor |
Security Level |
|
Mechanism |
Ticagrelor: CYP3A4 Inhibitors (Strong) may decrease serum concentrations of the active metabolite(s) of Ticagrelor. CYP3A4 Inhibitors (Strong) may increase the serum concentration of Ticagrelor. |
Management |
Avoid combination |
Boceprevir vs Ticagrelor
Post Review about Boceprevir vs Ticagrelor Click here to cancel reply.
Other Interactions of Boceprevir
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.